Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,273,151
+$38,974 QoQ
Shares Held
5,013
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#2,767
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. JNJ ranks #1 (28.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
5,013 | $1,273,151 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,077 | $767,768 | |
| 3 | LLY |
ELI LILLY & Co
|
551 | $660,885 | |
| 4 | AMGN |
Amgen Inc
|
1,633 | $591,341 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,026 | $517,341 | |
| 6 | ABBV |
AbbVie Inc.
|
1,228 | $309,013 | |
| 7 | PFE |
Pfizer Inc
|
11,973 | $288,309 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,273,151 | 5,013 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,234,177 | 5,049 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,057,514 | 5,110 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $952,873 | 5,139 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $792,467 | 5,188 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $869,664 | 5,244 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $782,394 | 5,410 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $900,891 | 5,559 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $811,918 | 5,555 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $874,316 | 5,527 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $868,809 | 5,543 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $857,248 | 5,504 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $918,139 | 5,547 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $858,390 | 5,538 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $899,501 | 5,092 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $919,880 | 5,631 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $1,038,966 | 5,853 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,018,718 | 5,748 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,018,550 | 5,954 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $971,422 | 6,015 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,071,963 | 6,507 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $1,120,538 | 6,818 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $981,264 | 6,235 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $861,419 | 5,786 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $816,075 | 5,803 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $704,561 | 5,373 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||